ObsEva SA (OBSEF)

Market Cap	11.72K
Revenue (ttm)	19.64M
Net Income (ttm)	7.92M
Shares Out	117.18M
EPS (ttm)	0.07
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	977
Average Volume	21,512
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	14.11
RSI	51.96
Earnings Date	n/a

About ObsEva

ObsEva SA, a biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health. It develops Nolasiban, an oral oxytocin receptor agonist for improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Employees: 15
• Stock Exchange: OTCMKTS
• Ticker Symbol: OBSEF

Financial Performance

In 2022, ObsEva's revenue was $19.64 million, a decrease of -11.55% compared to the previous year's $22.20 million. Losses were -$29.88 million, -43.60% less than in 2021.